Bio Tonsilla Phase

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Bio Tonsilla Phase
Generic name: DULCAMARA, ECHINACEA (ANGUSTIFOLIA), AESCULUS HIPPOCASTANUM, ANTIMONIUM TARTARICUM, ASCORBICUM ACIDUM, COCCUS CACTI, GALIUM APARINE, GENTIANA LUTEA, GERANIUM ROBERTIANUM, PULSATILLA (PRATENSIS), SARCOLACTICUM ACIDUM, ACETYLCHOLINE CHLORIDE, MANNOSE, CONIUM MACULATUM, LYMPH NODE (SUIS), SULPHUR, CALCAREA PHOSPHORICA, FUNICULUS UMBILICALIS SUIS, HEPAR SUIS, HYPOTHALAMUS SUIS, MEDULLA OSSIS SUIS, SPLEEN (SUIS), CORTISONE ACETICUM, GLANDULA SUPRARENALIS SUIS, MERCURIUS SOLUBILIS, THYROIDINUM (SUIS),
Manufacturer: Deseret Biologicals, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 74f899ed-8021-470a-995b-4822da412c50
SPL ID: fdf710b1-1c99-435c-871d-81e5e06e2257
Version: 4
Effective date: 2024-05-07
Source export date: 2026-09-28
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:56:00

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 36 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Bio Tonsilla Phase	openfda.brand_name
generic name		DULCAMARA, ECHINACEA (ANGUSTIFOLIA), AESCULUS HIPPOCASTANUM, ANTIMONIUM TARTARICUM, ASCORBICUM ACIDUM, COCCUS CACTI, GALIUM APARINE, GENTIANA LUTEA, GERANIUM ROBERTIANUM, PULSATILLA (PRATENSIS), SARCOLACTICUM ACIDUM, ACETYLCHOLINE CHLORIDE, MANNOSE, CONIUM MACULATUM, LYMPH NODE (SUIS), SULPHUR, CALCAREA PHOSPHORICA, FUNICULUS UMBILICALIS SUIS, HEPAR SUIS, HYPOTHALAMUS SUIS, MEDULLA OSSIS SUIS, SPLEEN (SUIS), CORTISONE ACETICUM, GLANDULA SUPRARENALIS SUIS, MERCURIUS SOLUBILIS, THYROIDINUM (SUIS),	openfda.generic_name
manufacturer name		Deseret Biologicals, Inc.	openfda.manufacturer_name
ndc	package	43742-1600-1	openfda.package_ndc
ndc	product	43742-1600	openfda.product_ndc
ndc11	package	43742160001	derived:openfda.package_ndc
spl id		fdf710b1-1c99-435c-871d-81e5e06e2257	id
spl set id		74f899ed-8021-470a-995b-4822da412c50	set_id
unii		6RV024OAUQ	openfda.unii
unii		KPS1B1162N	openfda.unii
unii		324Y4038G2	openfda.unii
unii		VP2CN2G7Y8	openfda.unii
unii		LZB7TFX1LT	openfda.unii
unii		883WKN7W8X	openfda.unii
unii		Q28R5GF371	openfda.unii
unii		S72O3284MS	openfda.unii
unii		6P669D8HQ8	openfda.unii
unii		TB08NIC03W	openfda.unii
unii		91D9GV0Z28	openfda.unii
unii		3C18L6RJAZ	openfda.unii
unii		DL6OZ476V3	openfda.unii
unii		33A7VYU29L	openfda.unii
unii		F9S9FFU82N	openfda.unii
unii		R5I1HK0UBL	openfda.unii
unii		PQ6CK8PD0R	openfda.unii
unii		VB06AV5US8	openfda.unii
unii		92AMN5J79Y	openfda.unii
unii		AF73293C2R	openfda.unii
unii		8E272251DI	openfda.unii
unii		398IYQ16YV	openfda.unii
unii		70FD1KFU70	openfda.unii
unii		118OYG6W3H	openfda.unii
unii		Z4B6561488	openfda.unii
unii		6EC706HI7F	openfda.unii
unii		N6R0856Z79	openfda.unii
unii		PHA4727WTP	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing. Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult a physician promptly. Do not use more than two days or administer to children under 3 years of age unless directed by a physician.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.